Cf 301-105 — Omaha, Nebraska

Cf 301-105 is a clinical research site located in Omaha, Nebraska, United States 68124.

Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.

Cf 301-105 has participated in 3 clinical trials.

Therapeutic areas: Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Endocarditis, Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia).

Sponsors: ContraFect.

Sponsor Feasibility Report

Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cf 301-105?

Cf 301-105 has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cf 301-105 conducted?

Cf 301-105 has 3 clinical trials on record. Their work covers Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Endocarditis, Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia).

Is Cf 301-105 accredited by Crixeo Health?

Cf 301-105 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cf 301-105?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.